AMSLS dietary habits and employment outcomes
16 March, 2021

New Australian research showcases the continuing work of the Australian MS Longitudinal Study (AMSLS) investigating dietary habits and employment outcomes.

Progressive MS - Scientists reading report
16 February, 2021

Updates from the International Progressive MS Alliance highlight progress and strategic plans to advance effective treatments for progressive MS.

24 November, 2020

Additional medical conditions can worsen MS symptoms and are an important target for intervention to improve quality of life for people with MS

ms medication successful
24 November, 2020

Another new medication for relapsing remitting MS has proved successful in clinical trials and gained approval for use in the US.

26 October, 2020

Mayzent (siponimod) the first MS medication approved for secondary progessive MS in Australia, has been listed on the Pharmaceutical Benefits Scheme (PBS).

major study MS and pregnancy
16 September, 2020

Major study into MS and pregnancy reveals it delays onset of MS symptoms by more than 3 years.

NMOSD medication
14 September, 2020

The Australian Therapeutic Goods Administration (TGA) has approved the first ever treatment for Neuromyelitis Optica Spectrum Disorders (NMOSD).

14 September, 2020

A panel of international experts have convened to develop new ways to measure disease progression in progressive MS, a major hurdle for clinical trials.

lifestyle guide for MS
27 August, 2020

Australian experts have teamed up with MS Research Australia to build an evidence-based lifestyle guide to help people living with MS.

Ozanimod approved for relapsing MS in Australia
18 August, 2020

Ozanimod has been approved by the TGA for the treatment of adults with relapsing forms of MS in Australia.

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search